Tianeptine-involved emergency department visits, fatal overdoses, and substance seizures in Tennessee, 2021-2023.

ABSTRACT:

Background

Tianeptine is an antidepressant that acts as an agonist to the mu-opioid receptor and enhances serotonin reuptake. Tianeptine has been legally sold as an antidepressant in some countries but is not approved for any medical use by the U.S. Food and Drug Administration (FDA). Tianeptine is not a federally controlled substance, but became a schedule II substance in Tennessee on July 1, 2022. This publication aims to describe the prevalence of tianeptine-involved emergency department visits, fatal overdoses, and substance seizures in Tennessee from 2021 to 2023.

Methods

We conducted a study to examine the prevalence of tianeptine-involved emergency department visits and fatal overdoses in Tennessee using data for 2021 to 2023 from the Tennessee Electronic Surveillance

SUBMITTER: Hershey HL 

PROVIDER: S-EPMC11386040 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature